Jump to section
About this journal
Aims and scope
Future Virology is a peer-reviewed journal covering basic, translational and clinical research in virology. The journal covers a wide range of topics, from new or re-emerging outbreaks to viral vectors, and looks at the impact on human health. A wide range of invited and unsolicited articles are considered, including original research, narrative and systematic reviews, and opinion pieces. The journal offers rapid and open access publishing options.
Articles published in Future Virology include key areas such as:
- The molecular basis of viral diseases
- Virus–host interactions
- New and re-emerging viruses
- Epidemiologic studies and trends
- Advances in oncolytic viral therapy, viral gene therapy and viral immunotherapy
- Vaccines and antiviral agents
- Adverse events and drug safety
- The problem of viral drug resistance, and potential methods to overcome this
- Pharmacoeconomics and cost–benefit issues in virology
- The use of viral vectors in gene therapy and functional genomics
- Defense against the use of viruses in bioterrorism
- Real world evidence and outcomes research
The journal welcomes unsolicited article proposals.
Journal metrics
Citation metrics
- 2.1 (2023) Impact Factor
- 1.7 (2023) 5 year IF
- 4.0 (2023) CiteScore (Scopus)
- 0.300 (2023) SNIP
- 0.366 (2023) SJR
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Shizou Akira, Osaka University, Japan
Brian Conway, University of British Columbia, Canada
Erik De Clercq, Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium
Robert C Gallo, University of Maryland Baltimore, USA
Thomas Harrer, University of Erlangen-Nuremberg, Germany
David Harrich, Queensland Institute of Medical Research, Australia
Hans H Hirsch, University of Basel, Switzerland
Nesrina Imami,Imperial College London, UK
Gene D Morse,University of Buffalo, NY, USA
Bill Powderly, Institute for Public Health, Washington University in St. Louis, USA
John J Rossi, Beckman Research Institute of the City of Hope, USA
David J Rowlands, University of Leeds, UK
Stefano Rusconi, Universita Degli Studi di Milano, Italy
Justin Stebbing, Imperial College London, UK
Milad Zandi, Tehran University of Medical Sciences, Iran
Chunfu Zheng, University of Calgary, Canada
Open access
Future Virology is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Use our APC finder to calculate your article publishing charge
18 issues per year
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors